These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 9058725)

  • 1. Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias.
    Fischer K; Fröhling S; Scherer SW; McAllister Brown J; Scholl C; Stilgenbauer S; Tsui LC; Lichter P; Döhner H
    Blood; 1997 Mar; 89(6):2036-41. PubMed ID: 9058725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular cytogenetic characterization of a critical region in bands 7q35-q36 commonly deleted in malignant myeloid disorders.
    Döhner K; Brown J; Hehmann U; Hetzel C; Stewart J; Lowther G; Scholl C; Fröhling S; Cuneo A; Tsui LC; Lichter P; Scherer SW; Döhner H
    Blood; 1998 Dec; 92(11):4031-5. PubMed ID: 9834205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases.
    Le Beau MM; Espinosa R; Davis EM; Eisenbart JD; Larson RA; Green ED
    Blood; 1996 Sep; 88(6):1930-5. PubMed ID: 8822909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural aberrations of chromosome 7 revealed by a combination of molecular cytogenetic techniques in myeloid malignancies.
    Brezinová J; Zemanová Z; Ransdorfová S; Pavlistová L; Babická L; Housková L; Melichercíková J; Sisková M; Cermák J; Michalová K
    Cancer Genet Cytogenet; 2007 Feb; 173(1):10-6. PubMed ID: 17284364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular definition of a narrow interval at 7q22.1 associated with myelodysplasia.
    Johnson EJ; Scherer SW; Osborne L; Tsui LC; Oscier D; Mould S; Cotter FE
    Blood; 1996 May; 87(9):3579-86. PubMed ID: 8611680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia.
    Pedersen-Bjergaard J; Pedersen M; Roulston D; Philip P
    Blood; 1995 Nov; 86(9):3542-52. PubMed ID: 7579462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delineation of multiple deleted regions in 7q in myeloid disorders.
    Tosi S; Scherer SW; Giudici G; Czepulkowski B; Biondi A; Kearney L
    Genes Chromosomes Cancer; 1999 Aug; 25(4):384-92. PubMed ID: 10398433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of structural abnormalities in the 7q31.3 approximately q34 region in myeloid malignancies.
    González MB; Gutiérrez NC; García JL; Schoenmakers EF; Solé F; Calasanz MJ; San Miguel JF; Hernández JM
    Cancer Genet Cytogenet; 2004 Apr; 150(2):136-43. PubMed ID: 15066321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification of deletions and identification of cryptic translocations involving 7q by fluorescence in situ hybridization (FISH).
    Tosi S; Harbott J; Haas OA; Douglas A; Hughes DM; Ross FM; Biondi A; Scherer SW; Kearney L
    Leukemia; 1996 Apr; 10(4):644-9. PubMed ID: 8618441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of the acetylcholinesterase locus at 7q22 associated with myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML).
    Stephenson J; Czepulkowski B; Hirst W; Mufti GJ
    Leuk Res; 1996 Mar; 20(3):235-41. PubMed ID: 8637218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of a myelodysplasia-associated chromosome 7 inversion.
    Todd R; Bia B; Johnson E; Jones C; Cotter F
    Br J Haematol; 2001 Apr; 113(1):143-52. PubMed ID: 11328294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?
    Lessard M; Hélias C; Struski S; Perrusson N; Uettwiller F; Mozziconacci MJ; Lafage-Pochitaloff M; Dastugue N; Terré C; Brizard F; Cornillet-Lefebvre P; Mugneret F; Barin C; Herry A; Luquet I; Desangles F; Michaux L; Verellen-Dumoulin C; Perrot C; Van den Akker J; Lespinasse J; Eclache V; Berger R;
    Cancer Genet Cytogenet; 2007 Jul; 176(1):1-21. PubMed ID: 17574959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-923.1 in lymphoproliferative disorders.
    Stilgenbauer S; Liebisch P; James MR; Schröder M; Schlegelberger B; Fischer K; Bentz M; Lichter P; Döhner H
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11837-41. PubMed ID: 8876224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic analysis of de novo acute myeloid leukemia with trilineage myelodysplasia in comparison with myelodysplastic syndrome evolving to acute myeloid leukemia.
    Tamura S; Takemoto Y; Hashimoto-Tamaoki T; Mimura K; Sugahara Y; Senoh J; Furuyama JI; Kakishita E
    Int J Oncol; 1998 Jun; 12(6):1259-62. PubMed ID: 9592183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype.
    Cuneo A; Bigoni R; Cavazzini F; Bardi A; Roberti MG; Agostini P; Tammiso E; Ciccone N; Mancini M; Nanni M; De Cuia R; Divona M; La Starza R; Crescenzi B; Testoni N; Rege Cambrin G; Mecucci C; Lo Coco F; Saglio G; Castoldi G
    Leukemia; 2002 Sep; 16(9):1745-51. PubMed ID: 12200689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletions of PURA, at 5q31, and PURB, at 7p13, in myelodysplastic syndrome and progression to acute myelogenous leukemia.
    Lezon-Geyda K; Najfeld V; Johnson EM
    Leukemia; 2001 Jun; 15(6):954-62. PubMed ID: 11417483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence in situ hybridization mapping of translocations and deletions involving the short arm of human chromosome 12 in malignant hematologic diseases.
    Kobayashi H; Montgomery KT; Bohlander SK; Adra CN; Lim BL; Kucherlapati RS; Donis-Keller H; Holt MS; Le Beau MM; Rowley JD
    Blood; 1994 Nov; 84(10):3473-82. PubMed ID: 7949101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular anatomy of chromosome 7q deletions in myeloid neoplasms: evidence for multiple critical loci.
    Liang H; Fairman J; Claxton DF; Nowell PC; Green ED; Nagarajan L
    Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3781-5. PubMed ID: 9520444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duplication or amplification of chromosome band 11q23, including the unrearranged MLL gene, is a recurrent abnormality in therapy-related MDS and AML, and is closely related to mutation of the TP53 gene and to previous therapy with alkylating agents.
    Andersen MK; Christiansen DH; Kirchhoff M; Pedersen-Bjergaard J
    Genes Chromosomes Cancer; 2001 May; 31(1):33-41. PubMed ID: 11284033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of chromosome arm 3p in hematologic malignancies.
    Johansson B; Billström R; Kristoffersson U; Akerman M; Garwicz S; Ahlgren T; Malm C; Mitelman F
    Leukemia; 1997 Aug; 11(8):1207-13. PubMed ID: 9264371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.